QS Batterymarch Financial Management’s Alaunos Therapeutics TCRT Stock Holding History

QS Batterymarch Financial Management’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$4K	Buy	+10	New	+$4.82K	﹤0.01%	898

Other funds holding TCRT

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

QS Batterymarch Financial Management's TCRT Position: Q3 2014 in Review

QS Batterymarch Financial Management opened a new position in Alaunos Therapeutics (TCRT) in Q3 2014: 10 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #898 among its holdings.

94 funds tracked by Wall St. Rank hold TCRT as of Q3 2014.

QS Batterymarch Financial Management held 10 shares of Alaunos Therapeutics worth $4K as of Q3 2014.
Alaunos Therapeutics was a new QS Batterymarch Financial Management position in Q3 2014.
Alaunos Therapeutics made up ﹤0.01% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #898 holding.
94 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.